Cherwell Software, maker of a “flexible IT service management” platform, has closed on $25 million in new funding from Insight Venture Partners. The minority investment will go toward growth and continued development. As part of the deal, Insight MD Richard Wells will join Cherwell’s board.
3 min read · 27 November 2012
Edison Pharmaceuticals has closed a $20 million Series F round, the company announced. Mitsui & Co. Global Investment Inc. led the financing. The money will go toward clinical development of the company’s products.
1 min read · 27 November 2012
Sopogy, a solar thermal technology company based in Hawaii, has raised an undisclosed amount of Series E financing, it announced. The round included preferred stock and warrants, and was led by Mitsui & Co. Southern California Gas Company, 3M, Kolohala Ventures and Enerdigm Ventures also joined the round.
2 min read · 27 November 2012
Endosense, a developer of technology for catheter ablation for the treatment of cardiac arrhythmias, has raised $40.3 million in Series C financing. new investor NGN Capital led the round, which included investment from existing investors Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie. Endosense was formed in Geneva in 2003.
3 min read · 27 November 2012
Hello Health, a maker of “electronic health revenue” and patient management software, has raised $11.5 million in new financing. The company has raised more than $20 million in the past year. First Generation Capital led the round.
2 min read · 26 November 2012
ownCloud Inc., a maker of open source file sync and share software, has closed a $2.5 million seed round, the company announced Monday. General Catalyst Partners led the round. ownCloud is based in Lexington, Mass.
2 min read · 26 November 2012
Greg Bohlen says he sees a good opportunity in venture and believes that “private equity as a whole is likely to continue to outperform the general market by a fairly wide margin.”
2 min read · 19 November 2012
Intarcia Therapeutics Inc., a privately held biotech company, has completed two financings totaling $210 million. The financing includes $160 million in preferred stock private placement and $50 million in debt financing. Investors include New Enterprise Associates, New Leaf Venture Partners, Venrock, The Baupost Group, and Farallon Capital Management.
5 min read · 16 November 2012
Montreal-based Fortem, maker of 3D security systems, has sealed $1.43 million in new financing. The investment came from seven members of the Anges Québec group, the Anges Québec Capital fund, and other private investors. The company is targeting a total of $3.5 million for the round, which remains open until early next year, the company said in a press release.
3 min read · 16 November 2012
Innovent Biologics Inc., which is manufacturing “monoclonal antibodies,” has raised $25 million in Series B financing. The money comes from Lilly Asia Ventures and from Fidelity Biosciences and Fidelity Growth Partners Asia. Innovent’s antibodies are to be marketing in China and elsewhere around the globe.
2 min read · 16 November 2012
